Research from rodent, non-human primate, and human studies supports the idea that aberrant LHb activity is closely linked to depressive symptoms. Hyperactivity of the LHb has been associated with helplessness, anhedonia (lack of pleasure), and excessive negative focus. This overactivity is thought to suppress reward-related signaling, thereby reinforcing depressive states and contributing to the persistence of symptoms.
Given its central role in depression, the LHb has become a major focus of neuroscience research, particularly in the quest for novel antidepressant treatments. Ketamine, a well-known rapid-acting antidepressant, induces a dose-dependent inhibition of spontaneous lateral habenula activity. This is in line with previous findings describing the hyperactivity of the lateral habenula (LHb) in depression models and the ability of ketamine to restore normal firing patterns, contributing to its antidepressant effects.
Microelectrode array (MEA) technology provides a powerful platform for studying habenula spontaneous firing activity with multi-site and long-lasting recording capabilities and can be relevant for screening potential antidepressant compounds by assessing their effects on habenular network activity in a robust and reproducible manner.
Watch our short video to explore how this approach supports antidepressant research and helps visualize ketamine’s effects on LHb neuronal firing.
Contact us today to learn how MEA technology can enhance your research and accelerate drug development!
